Madrigal Pharmace…
USUSDMadrigal Pharmaceuticals Inc (US:MDGL) — Biotechnology: Pharmaceutical Preparations. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 2. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
Par Uzņēmumu
- Tīmekļvietne
- madrigalpharma.com
- Investoru Attiecības
- ir.madrigalpharma.com/
- Nozare
- Health Care · Biotechnology: Pharmaceutical Preparations
- Galvenā Mītne
- WEST CONSHOHOCKEN, United States
- Izpilddirektors
- William J. Sibold
- Darbinieki
- 915
- Apgrozībā Esošās Akcijas
- 23.1 milj. uz 2026-07-27
- Brīvā Apgrozība
- 13.72 milj.
- Tirgus Kapitalizācija
- 10.9 mljrd. USD
- Iekšējās Personas
- 5.83%
- Institucionālie Investori
- 104.65%
- Nozare (SIC)
- Pharmaceutical Preparations
- P/E
- zaudējumi
- FCF
- −206 milj. USD
- Parāds
- 341 milj. USD
- Peļņa un FCF — par 12 mēnešiem līdz 30.06.2026 (uzņēmuma jaunākais ziņojums).
Apraksts
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
reklāma
Lielākie Akcionāri
| Turētājs | Daļa | Akcijas | Pārskata Datums |
|---|---|---|---|
| Baker Bros. Advisors, LP | 9.28% | 2.14 milj. | 2026-06-30 |
| RTW Investments LP | 8.63% | 1.99 milj. | 2026-06-30 |
| Jupiter Topco LLC | 8.38% | 1.94 milj. | 2026-06-30 |
| Avoro Capital Advisors L… | 7.94% | 1.83 milj. | 2026-06-30 |
| PAULSON & CO. INC. | 5.8% | 1.34 milj. | 2026-06-30 |
| Blackrock Inc. | 5.2% | 1.2 milj. | 2026-06-30 |
| TAUB REBECCA A. (Directo… | ≈4.8% | 1.11 milj. | 2026-06-17 |
| FRIEDMAN PAUL A (Directo… | ≈3.65% | 842 704 | 2026-01-09 |
| Vanguard Capital Managem… | 3.62% | 835 668 | 2026-06-30 |
| Wellington Management Gr… | 3.57% | 825 714 | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.38% | 781 731 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.53% | 584 997 | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 2.44% | 563 117 | 2026-07-31 |
| State Street Corporation | 2.28% | 527 057 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.83% | 423 142 | 2026-06-30 |
| CRAVES FREDERICK B (Dire… | ≈1.66% | 383 547 | 2025-03-13 |
| JANUS INVESTMENT FUND-Ja… | 1.47% | 338 602 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.05% | 243 683 | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 1.01% | 233 269 | 2026-06-30 |
| SPDR SERIES TRUST-State… | 0.96% | 222 407 | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 0.94% | 216 882 | 2026-06-30 |
| SIBOLD WILLIAM JOHN (Chi… | ≈0.86% | 197 746 | 2026-09-11 |
| Vanguard Explorer Fund | 0.82% | 190 140 | 2026-07-31 |
| First TRT Exch-Trd Fd.-F… | 0.73% | 168 689 | 2026-08-31 |
| LEVY RICHARD S (Director… | ≈0.1% | 22 469 | 2026-06-17 |
| HUNTSMAN CAROLE A (Offic… | ≈0.05% | 12 692 | 2026-03-06 |
| DIER MARDI C (Chief Fina… | ≈0.05% | 12 490 | 2026-03-06 |
| KELLEY SHANNON T (Genera… | ≈0.05% | 11 474 | 2026-08-17 |
| SOERGEL DAVID (Officer) | ≈0.05% | 11 075 | 2026-05-18 |
| BAKER BROS ADVISORS, L.P… | — | — | 2026-06-17 |
